Camilla Muccini Selected Research

Camilla Muccini Research Topics

6	Infections 03/2022 - 01/2019
4	Viremia 10/2021 - 12/2019
4	HIV Infections (HIV Infection) 01/2021 - 01/2019
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 01/2019
2	Hypertension (High Blood Pressure) 11/2021 - 01/2021
2	Inflammation (Inflammations) 10/2021 - 01/2018
1	Neoplasms (Cancer) 03/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Weight Gain 11/2021
1	Insulin Resistance 11/2021
1	Hepatitis C 01/2021
1	Hypercholesterolemia 01/2021
1	Syphilis 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	COVID-19 10/2020
1	Persistent Infection 12/2019
1	Hyperbilirubinemia 12/2018

6	RNA (Ribonucleic Acid)IBA 10/2021 - 01/2019
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2018
3	IntegrasesIBA 03/2022 - 01/2021
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2021
2	tenofovir alafenamideIBA 11/2021 - 01/2021
2	dolutegravirIBA 11/2021 - 01/2021
2	Immunoglobulin G (IgG)IBA 01/2021 - 10/2020
1	ibalizumabIBA 03/2022
1	Enfuvirtide (Fuzeon)FDA Link 03/2022
1	Integrase InhibitorsIBA 03/2022
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 01/2022
1	HLA-B39 AntigenIBA 01/2022
1	fostemsavirIBA 01/2022
1	Raltegravir Potassium FDA Link 11/2021
1	Reverse Transcriptase InhibitorsIBA 01/2021
1	Emtricitabine (Emtriva)FDA Link 01/2021
1	CobicistatIBA 01/2021
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2021
1	ReaginsIBA 01/2021
1	TabletsIBA 01/2021
1	Immunoglobulin M (IgM)IBA 10/2020
1	AntibodiesIBA 04/2020
1	Monoclonal AntibodiesIBA 01/2019
1	VaccinesIBA 01/2019
1	BilirubinIBA 12/2018
1	cupric sulfide (CuS)IBA 12/2018
1	Hepatitis C AntibodiesIBA 12/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2018
1	LDL CholesterolIBA 12/2018
1	HDL CholesterolIBA 12/2018
1	Triglycerides (Triacylglycerol)IBA 12/2018
1	Atazanavir Sulfate (Reyataz)FDA Link 12/2018